In patients with severe gastrointestinal motility disorders, such as gastroparesis, this pharmacologic effect can intensify symptoms
For a broader look at what side effects mean and when they signal a need for dose adjustment versus normal adaptation, our semaglutide troubleshooting guide covers the most common scenarios
The trial, funded by Novo Nordisk, the manufacturer of Wegovy (semaglutide), found the drug improved liver inflammation, scarring (fibrosis), and sometimes both in people with metabolic dysfunction-associated steatohepatitis (MASH)
If youre interested in losing weight with semaglutide, look no further than The Sanctuary Wellness Institute
A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk